ArticleTherapeutic innovation & regulatory science2022

Over-Prescription of the Imidazoline Receptor Agonists: Evidence for Restriction of the Therapeutic Indication.

Rimas Jankūnas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.